Summit Therapeutics Inc.SMMTNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% below average
Average (39q)
285.54%
Historical baseline
Range
High:5310.43%
Low:-100.00%
Volatility
1894.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | -100.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -100.00% |
| Q4 2022 | -99.68% |
| Q3 2022 | -6.38% |
| Q2 2022 | -6.00% |
| Q1 2022 | -0.40% |
| Q4 2021 | -80.83% |
| Q3 2021 | 2196.49% |
| Q2 2021 | -70.31% |
| Q1 2021 | 3.78% |
| Q4 2020 | 2.21% |
| Q3 2020 | 6.47% |
| Q2 2020 | -47.53% |
| Q1 2020 | 2661.21% |
| Q4 2019 | -92.66% |
| Q4 2019 | 4.40% |
| Q3 2019 | -52.41% |
| Q2 2019 | -86.56% |
| Q1 2019 | 179.33% |
| Q4 2018 | -98.28% |
| Q3 2018 | 834.68% |
| Q2 2018 | 25.12% |
| Q1 2018 | 86.81% |
| Q4 2017 | -90.84% |
| Q3 2017 | 1015.00% |
| Q2 2017 | 3.43% |
| Q1 2017 | 207.10% |
| Q4 2016 | 5310.43% |
| Q3 2016 | -77.97% |
| Q2 2016 | -73.54% |
| Q1 2016 | -31.60% |